Cogstim:一个共享决策模型,以支持老年人的大脑健康
Raymond L Ownby1, Drenna Waldrop2
1Department of Psychiatry and Behavioral Medicine, Nova Southeastern University, Fort Lauderdale, FL, 33316, USA.
Current Alzheimer research
|May 26, 2023
概括
生活方式干预表明,它有望预防老年人的认知衰退和痴呆症. 一个新的共享决策模型有助于临床医生指导患者选择个性化的大脑健康计划,以减少痴呆风险.
科学领域:
- 老年学是一门学科.
- 神经科学是一个神经科学.
- 公共卫生 公共卫生
背景情况:
- 老年人认知能力下降的有效治疗方法缺乏,人们对生活方式干预的兴趣越来越大.
- 多种生活方式因素与认知衰退有关,干预措施显示出积极的认知影响.
- 将这些发现转化为老年人实用的临床模型仍然是一个挑战.
研究的目的:
- 为临床医生提出一个共享的决策模式,以促进老年人大脑健康.
- 将认知衰退的风险和保护因素组织成可操作的类别.
- 授权老年人为大脑健康计划做出明智的选择.
主要方法:
- 介绍了一个共享决策模型,根据行动机制组织因素.
- 该模型为基于证据和偏好的目标选择提供了信息.
- 它包括行为改变策略,如设定目标,自我监测和解决问题.
主要成果:
- 该模型促进了个性化,有效的脑健康生活方式的发展.
- 它支持临床医生在老年人群中促进大脑健康.
- 实施旨在降低认知能力下降的风险.
结论:
- 一个共享的决策模型可以将生活方式干预发现转化为临床实践.
- 这种方法支持老年人采用大脑健康的行为.
- 该模型有可能减轻认知能力下降和痴呆症风险.
相关概念视频
Alzheimer's Disease: Treatment
226
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
226
Alzheimer's Disease: Overview
541
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
541
Cognitive Development During Adulthood
166
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
166
Decision Making
154
Decision-making is a fundamental cognitive process that involves evaluating alternatives and selecting among them. This process can range from simple choices, such as deciding what to wear, to complex decisions, like choosing a major in college or a career path. The complexity of the decision often dictates the approach we use, which can be broadly categorized into two types: automatic and controlled decision-making.
Automatic decision-making is fast, intuitive, and relies on gut feelings...
Automatic decision-making is fast, intuitive, and relies on gut feelings...
154
Aging
92
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
92
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
166
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
166


